Vertex provides another EPS beat as net income rises 56% in Q1
https://seekingalpha.com/news/4100817-vertex-provides-another-eps-beat-net-income-rises-56-q1?source=feed_sector_healthcare
May 06, 2024 - Vertex Pharmaceuticals reports strong Q1 results with a 56% surge in net income. Read more on VRTX stock's earnings card here.
0
Tenet Healthcare (THC) Beats on Q1 Earnings, Ups '24 EPS View
https://www.zacks.com/stock/news/2266339/tenet-healthcare-thc-beats-on-q1-earnings-ups-24-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2266339
May 01, 2024 - Tenet Healthcare's (THC) Q1 results reflect strength in admissions and improved pricing yield. It expects an adjusted EPS of $8.37-$9.41 for 2024, higher than the earlier mentioned $5.76-$6.90.
0
New Gold Non-GAAP EPS of $0.02 beats by $0.02, revenue of $192.1M beats by $4.64M
https://seekingalpha.com/news/4096934-new-gold-non-gaap-eps-of-0_02-beats-0_02-revenue-of-192_1m-beats-4_64m?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Apr 30, 2024 - New Gold (NGD) reports impressive Q1 results, with Non-GAAP EPS beating expectations by $0.02 and revenue surpassing estimates by $4.64M.
0
HSBC Holdings Non-GAAP EPS of $0.34, revenue of $20.8B; Group CEO Noel Quinn to retire
https://seekingalpha.com/news/4095943-hsbc-holdings-non-gaap-eps-of-034-revenue-of-208b-reaffirms-fy24-outlook?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Apr 29, 2024 - HSBC Holdings press release (HSBC): Q1 Non-GAAP EPS of $0.34; GAAP EPS of $0.54.
Revenue of $20.8B (+3.0% Y/Y).
Net interest income of $8.7B fell by $0.3B.
0
Centene (CNC) Q1 Earnings Beat on Premiums, '24 EPS View Hiked
https://www.zacks.com/stock/news/2263590/centene-cnc-q1-earnings-beat-on-premiums-24-eps-view-hiked?cid=CS-ZC-FT-analyst_blog|earnings_article-2263590
Apr 26, 2024 - Centene's (CNC) Q1 results reflect strength in the Commercial business line. Management currently expects adjusted EPS to be greater than $6.80 for 2024.
0
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
https://www.zacks.com/stock/news/2263588/abbvie-abbv-beats-on-q1-earnings-sales-ups-24-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2263588
Apr 26, 2024 - AbbVie's (ABBV) first-quarter earnings and sales beat estimates. Management hikes the EPS guidance on the back of encouraging Skyrizi product sales.
0
Gilead has strong Q1, but updated 2024 EPS guidance range misses consensus
https://seekingalpha.com/news/4094663-gilead-strong-q1-but-updated-2024-eps-guidance-range-misses-consensus?source=feed_sector_healthcare
Apr 25, 2024 - Gilead Sciences reports Q1 2024 financial results with a diluted EPS loss due to charges from acquisitions and updates 2024 guidance ranges. Read more here.
0
ICON adjusts 2024 revenue, EPS guidance ranges
https://seekingalpha.com/news/4093762-icon-adjusts-2024-revenue-eps-guidance-ranges?source=feed_sector_healthcare
Apr 24, 2024 - Clinical research organization ICON adjusts 2024 outlook for revenue and adjusted EPS. Read more here.
0
GATX Surpasses Q1 Earnings Estimates, Reaffirms 2024 EPS View
https://www.zacks.com/stock/news/2261537/gatx-surpasses-q1-earnings-estimates-reaffirms-2024-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2261537
Apr 24, 2024 - GATX's first-quarter 2024 earnings decrease year over year while revenues improve.
0
S&P 500 stocks with biggest estimated EPS declines for Q1
https://seekingalpha.com/news/4092482-sp-500-stocks-with-biggest-estimated-eps-decrease-this-season?source=feed_sector_healthcare
Apr 23, 2024 - Moderna (MRNA), Ventas (VTR) and American Airlines (AAL) are among the S&P 500 companies with the greatest expected Y/Y decreases in EPS
0
Page 1>